Series C - Pendulum Therapeutics

Series C - Pendulum Therapeutics

Investment Firm

Overview

Pendulum Therapeutics is a biotechnology firm improving health through products targeting the microbiome.

Announced Date

Apr 07, 2021

Funding Type

Series C

Highlights

Location

United States, North America

Social

Investor Lead

Meritech Capital Partners

Meritech Capital Partners

Meritech Capital Partners is a early_stage_venture and late_stage_venture and private_equity and venture firm.

Participant Investors

4

Investor Name
Participant InvestorMeritech Capital Partners
Participant InvestorSequoia Capital
Participant InvestorKhosla Ventures
Participant InvestorTrue Ventures

Round Details and Background

Pendulum Therapeutics raised $54000000 on 2021-04-07 in Series C

Pendulum Therapeutics is a biotechnology firm improving health through products targeting the microbiome.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 07, 2021
Series C - Pendulum Therapeutics
4-54.0M
Feb 09, 2023
Venture Round - Pendulum Therapeutics
1-undefined
Jun 09, 2023
Venture Round - Pendulum Therapeutics
2-10.0M
Feb 20, 2024
Series C - Pendulum Therapeutics
1-undefined

Recent Activity

There is no recent news or activity for this profile.